Opko Health (OPK) Enterprise Value (2010 - 2026)

Opko Health (OPK) has 17 years of Enterprise Value data on file, last reported at -$300.8 million in Q2 2026.

• Quarterly Enterprise Value fell 10.69% year-over-year to -$300.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$300.8 million (down 10.69% YoY) and the FY2025 annual result came in at -$369.1 million, up 14.55% from the prior year.
• Enterprise Value climbed to -$300.8 million in Q2 2026, from -$341.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$40.6 million in Q2 2024 to a low of -$436.0 million in Q1 2025.
• A 5-year average of -$232.7 million and a median of -$195.6 million in 2022 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2024 — Enterprise Value soared 62.47% — and 2025, when it slumped 569.65%.
• Tracing OPK's Enterprise Value over 5 years: stood at -$153.2 million in 2022, then jumped by 37.41% to -$95.9 million in 2023, then plunged by 350.49% to -$431.9 million in 2024, then climbed by 14.55% to -$369.1 million in 2025, then increased by 18.51% to -$300.8 million in 2026.
• The last three Enterprise Value figures came in at -$300.8 million (Q2 2026), -$341.9 million (Q1 2026), and -$369.1 million (Q4 2025), per Business Quant data.